Serdolect

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Sertindole 20mg

Disponible depuis:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

DCI (Dénomination commune internationale):

Sertindole 20 mg

Dosage:

20 mg

forme pharmaceutique:

Film coated tablet

Composition:

Active: Sertindole 20mg Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose Opadry pink 03B24282

Unités en paquet:

Blister pack, PVC/PVDC/Al, 20 tablets

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Lundbeck Pharmaceuticals Italy SpA

indications thérapeutiques:

Sertindole is indicated for the treatment of schizophrenia. Due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. Sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al - 20 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 28 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 30 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 50 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 98 tablets - 60 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Al - 100 tablets - 60 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

2006-04-13